Page last updated: 2024-11-10

1-palmitoyl-2-oleoylphosphatidylethanolamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-palmitoyl-2-oleoylphosphatidylethanolamine: RN given refers to (Z)-isomer; RN for cpd without isomeric designation not available 12/88 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-palmitoyl-2-oleoyl phosphatidylethanolamine : A phosphatidylethanolamine in which the phosphatidyl acyl groups at C-1 and C-2 are palmitoyl and oleoyl respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5282290
CHEBI ID60286
SCHEMBL ID20214623
MeSH IDM0160997

Synonyms (18)

Synonym
1-palmitoyl-2-oleoylphosphatidylethanolamine
2-oleoyl-1-palmitoyl phosphatidylethanolamine
3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(9z)-octadec-9-enoyloxy]propyl hexadecanoate
pope
1-pops
10015-88-0
CHEBI:60286 ,
2-oleoyl-1-palmitoylphosphatidylethanolamine
1-palmitoyl-2-oleoyl phosphatidylethanolamine
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (z)-octadec-9-enoate
9-octadecenoic acid (z)-, 1-((((2-aminoethoxy)hydroxyphosphinyl)oxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl ester
EPITOPE ID:136782
SCHEMBL20214623
Q27127166
1-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-3-(palmitoyloxy)propan-2-yl oleate
STARBLD0007244
DTXSID201256135
pe 16:0_18:1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
phosphatidylethanolamineA class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxy group of ethanolamine.
(18R,21S)-24-amino-21-hydroxy-21-oxido-15-oxo-16,20,22-trioxa-21lambdalambda(5)-phosphatetracosan-18-yl icosanoate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (294)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (2.72)18.7374
1990's40 (13.61)18.2507
2000's90 (30.61)29.6817
2010's145 (49.32)24.3611
2020's11 (3.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.58 (24.57)
Research Supply Index5.70 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.34%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other296 (99.66%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]